People using semaglutide to treat diabetes or lose weight may be at higher risk of developing a condition that causes sudden sight loss, according to a new study.
People using popular weight-loss jabs Ozempic and Wegovy may be at higher risk of developing an eye condition that can cause blindness, according to a new study. Semaglutide is the active ingredient in injections used to treat diabetes and prescribed to help people lose weight. People with diabetes prescribed semaglutide were more than four times more likely to be diagnosed with a condition called non-arteritic anterior ischemic optic neuropathy , the study found.
and vision often does not improve. The new study, published in JAMA Ophthalmology, was led by Joseph Rizzo, a professor of ophthalmology at Harvard Medical School in the US. He said use of the drugs has 'exploded' - but in future doctors should discuss the potential risk of is thought to affect 10 out of 100,000 people in the general population. Prof Rizzo and his colleagues decided to investigate a potential link between semaglutide and
in one week. To investigate possible links, researchers examined data from more than 16,000 patients from Mass Eye and Ear treated over a six-year period. They compared patients who had received prescriptions for semaglutide with those taking other diabetes or weight-loss drugs. Over three years, 8.9% people on semaglutide for diabetes had
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Weight loss jabs like Ozempic and Wegovy cut risk of bowel cancer by halfLeading doctor, Dr Mark Hyman, warns of deadly unforeseen side effects of Ozempic: 'It raises your risk 900 PERCENT' on The Diary of a CEO podcast.
Read more »
Weight loss jabs like Ozempic and Wegovy cut risk of bowel cancer by halfLeading doctor, Dr Mark Hyman, warns of deadly unforeseen side effects of Ozempic: 'It raises your risk 900 PERCENT' on The Diary of a CEO podcast.
Read more »
Wegovy and Ozempic linked to reduced incidence and recurrence of alcohol abuse or dependence, study suggestsResearchers investigated the potential therapeutic benefits of semaglutide for alcohol use disorders.
Read more »
‘Skinny jabs’ like Ozempic and Wegovy could trigger terrifying eye condition and leave you BLIND...Sun Health Explainer: Fat jabs
Read more »
Novo Nordisk says weight-loss drug Wegovy approved in ChinaNovo Nordisk's flagship weight-loss drug Wegovy has been approved for use in China, the Danish pharmaceutical giant said.
Read more »
Novo Nordisk weight loss drug Wegovy approved in ChinaMove opens market with growing rates of obesity to Danish group’s blockbuster drug
Read more »